Research reading
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale demand and the China (CHN) to Pakistan (PAK) lane
Pakistan (PAK) reported $398.1K of medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale imports in 2023. China (CHN) accounted for 0.4% of the observed market and reported $7.7K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +10.4% buyer growth and +2.8% exporter growth. The page separates reported values from projections and indicators.
